We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Post-Operative Pain - Pipeline Review, H1 2019

Published: April 2019
Pages: 265
Code: 891B9D71944F961825868199355825BB
Format: PDF
Publisher Global Markets Direct
From Add to basket
$ 2,000.00
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide , provides an overview of the Post-Operative Pain (Central Nervous System) pipeline landscape.
Pain is one of the main postoperative adverse outcomes causing distress to patients. Degree of postoperative pain experienced by individuals varies. Cause of pain includes peripheral nerve damage during surgery, inflammation at the site of the wound and damage to bodily tissues during surgery. Risk factors include site of the operation, age, level of fear or anxiety, surgical procedure, personal preference and response to agents given. Treatment for post-operative pain includes analgesia and anesthetics.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide , provides comprehensive information on the therapeutics under development for Post-Operative Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Post-Operative Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 4, 8, 22, 9, 4, 32, 2 and 1 respectively. Similarly, the Universities portfolio in Phase III and Preclinical stages comprises 1 and 3 molecules, respectively.
Post-Operative Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Additonal Information

  • - The pipeline guide provides a snapshot of the global therapeutic landscape of Post-Operative Pain (Central Nervous System).
  • - The pipeline guide reviews pipeline therapeutics for Post-Operative Pain (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • - The pipeline guide reviews key companies involved in Post-Operative Pain (Central Nervous System) therapeutics and enlists all their major and minor projects.
  • - The pipeline guide evaluates Post-Operative Pain (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • - The pipeline guide reviews latest news related to pipeline therapeutics for Post-Operative Pain (Central Nervous System)

Companies Mentioned

Abide Therapeutics Inc
AcelRx Pharmaceuticals Inc
Adynxx Inc
AngioChem Inc
Aoxing Pharmaceutical Company Inc
Apsen Farmaceutica SA
Cadila Healthcare Ltd
Camurus AB
Cara Therapeutics Inc
Cellix Bio Pvt Ltd
CerSci Therapeutics Inc
Cytogel Pharma LLC
Dompe Farmaceutici SpA
DURECT Corp
Esteve Pharmaceuticals SA
Eupraxia Pharmaceuticals Inc
EyeGate Pharmaceuticals Inc
Fujimoto Pharmaceutical Corp
Grunenthal GmbH
Heron Therapeutics Inc
Immupharma Plc
Innocoll AG
Insys Therapeutics Inc
Ionis Pharmaceuticals Inc
iX Biopharma Ltd
Jiangsu Hengrui Medicine Co Ltd
Liquidia Technologies Inc
Lumosa Therapeutics Co Ltd
MedinCell SA
Medtronic Plc
Mundipharma International Ltd
Neumentum Inc
Novartis AG
Ocular Therapeutix Inc
Pacira Pharmaceuticals Inc
PainReform Ltd
Pharmaleads SA
PhytoHealth Corp
PixarBio Corp
PolyPid Ltd
RaQualia Pharma Inc
Recro Pharma Inc
Rottapharm Biotech Srl
Serina Therapeutics Inc
Shijiazhuang Yiling Pharmaceutical Co Ltd
Sichuan Kelun Pharmaceutical Co Ltd
SiteOne Therapeutics Inc
SteadyMed Therapeutics Inc
Taiwan Liposome Co Ltd
Teikoku Pharma USA Inc
Trevena Inc
Xigen SA
YiChang Humanwell Pharmaceutical Co Ltd

Reasons to buy

Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. Recognize emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage. Find and recognize significant and varied types of therapeutics under development for PostOperative Pain (Central Nervous System). Classify potential new clients or partners in the target demographic. Develop tactical initiatives by understanding the focus areas of leading companies. Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics. Formulate corrective measures for pipeline projects by understanding PostOperative Pain (Central Nervous System) pipeline depth and focus of Indication therapeutics. Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the knowhow what drove them from pipeline.
Add to basket
  • Table of Contents
  • Introduction
  • Post-Operative Pain - Overview
  • Post-Operative Pain - Therapeutics Development
  • Post-Operative Pain - Therapeutics Assessment
  • Post-Operative Pain - Companies Involved in Therapeutics Development
  • Post-Operative Pain - Drug Profiles
  • Post-Operative Pain - Dormant Projects
  • Post-Operative Pain - Discontinued Products
  • Post-Operative Pain - Product Development Milestones
  • Appendix
  • List of Tables
  • Number of Products under Development for Post-Operative Pain, H1 2019
  • Number of Products under Development by Companies, H1 2019
  • Number of Products under Development by Universities/Institutes, H1 2019
  • Products under Development by Companies, H1 2019
  • Products under Development by Universities/Institutes, H1 2019
  • Number of Products by Stage and Target, H1 2019
  • Number of Products by Stage and Mechanism of Action, H1 2019
  • Number of Products by Stage and Route of Administration, H1 2019
  • Number of Products by Stage and Molecule Type, H1 2019
  • Post-Operative Pain - Pipeline by Abide Therapeutics Inc, H1 2019
  • Post-Operative Pain - Pipeline by AcelRx Pharmaceuticals Inc, H1 2019
  • Post-Operative Pain - Pipeline by Adynxx Inc, H1 2019
  • Post-Operative Pain - Pipeline by AngioChem Inc, H1 2019
  • Post-Operative Pain - Pipeline by Aoxing Pharmaceutical Company Inc, H1 2019
  • Post-Operative Pain - Pipeline by Apsen Farmaceutica SA, H1 2019
  • Post-Operative Pain - Pipeline by Cadila Healthcare Ltd, H1 2019
  • Post-Operative Pain - Pipeline by Camurus AB, H1 2019
  • Post-Operative Pain - Pipeline by Cara Therapeutics Inc, H1 2019
  • Post-Operative Pain - Pipeline by Cellix Bio Pvt Ltd, H1 2019
  • Post-Operative Pain - Pipeline by CerSci Therapeutics Inc, H1 2019
  • Post-Operative Pain - Pipeline by Cytogel Pharma LLC, H1 2019
  • Post-Operative Pain - Pipeline by Dompe Farmaceutici SpA, H1 2019
  • Post-Operative Pain - Pipeline by DURECT Corp, H1 2019
  • Post-Operative Pain - Pipeline by Esteve Pharmaceuticals SA, H1 2019
  • Post-Operative Pain - Pipeline by Eupraxia Pharmaceuticals Inc, H1 2019
  • Post-Operative Pain - Pipeline by EyeGate Pharmaceuticals Inc, H1 2019
  • Post-Operative Pain - Pipeline by Fujimoto Pharmaceutical Corp, H1 2019
  • Post-Operative Pain - Pipeline by Grunenthal GmbH, H1 2019
  • Post-Operative Pain - Pipeline by Heron Therapeutics Inc, H1 2019
  • Post-Operative Pain - Pipeline by Immupharma Plc, H1 2019
  • Post-Operative Pain - Pipeline by Innocoll AG, H1 2019
  • Post-Operative Pain - Pipeline by Insys Therapeutics Inc, H1 2019
  • Post-Operative Pain - Pipeline by Ionis Pharmaceuticals Inc, H1 2019
  • Post-Operative Pain - Pipeline by iX Biopharma Ltd, H1 2019
  • Post-Operative Pain - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H1 2019
  • Post-Operative Pain - Pipeline by Liquidia Technologies Inc, H1 2019
  • Post-Operative Pain - Pipeline by Lumosa Therapeutics Co Ltd, H1 2019
  • Post-Operative Pain - Pipeline by MedinCell SA, H1 2019
  • Post-Operative Pain - Pipeline by Medtronic Plc, H1 2019
  • Post-Operative Pain - Pipeline by Mundipharma International Ltd, H1 2019
  • Post-Operative Pain - Pipeline by Neumentum Inc, H1 2019
  • Post-Operative Pain - Pipeline by Novartis AG, H1 2019
  • Post-Operative Pain - Pipeline by Ocular Therapeutix Inc, H1 2019
  • Post-Operative Pain - Pipeline by Pacira Pharmaceuticals Inc, H1 2019
  • Post-Operative Pain - Pipeline by PainReform Ltd, H1 2019
  • Post-Operative Pain - Pipeline by Pharmaleads SA, H1 2019
  • Post-Operative Pain - Pipeline by PhytoHealth Corp, H1 2019
  • Post-Operative Pain - Pipeline by PixarBio Corp, H1 2019
  • Post-Operative Pain - Pipeline by PolyPid Ltd, H1 2019
  • Post-Operative Pain - Pipeline by RaQualia Pharma Inc, H1 2019
  • Post-Operative Pain - Pipeline by Recro Pharma Inc, H1 2019
  • Post-Operative Pain - Pipeline by Rottapharm Biotech Srl, H1 2019
  • Post-Operative Pain - Pipeline by Serina Therapeutics Inc, H1 2019
  • Post-Operative Pain - Pipeline by Shijiazhuang Yiling Pharmaceutical Co Ltd, H1 2019
  • Post-Operative Pain - Pipeline by Sichuan Kelun Pharmaceutical Co Ltd, H1 2019
  • Post-Operative Pain - Pipeline by SiteOne Therapeutics Inc, H1 2019
  • Post-Operative Pain - Pipeline by SteadyMed Therapeutics Inc, H1 2019
  • Post-Operative Pain - Pipeline by Taiwan Liposome Co Ltd, H1 2019
  • Post-Operative Pain - Pipeline by Teikoku Pharma USA Inc, H1 2019
  • List of Figures
  • Number of Products under Development for Post-Operative Pain, H1 2019
  • Number of Products under Development by Companies, H1 2019
  • Number of Products under Development by Universities/Institutes, H1 2019
  • Number of Products by Top 10 Targets, H1 2019
  • Number of Products by Stage and Top 10 Targets, H1 2019
  • Number of Products by Top 10 Mechanism of Actions, H1 2019
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019
  • Number of Products by Top 10 Routes of Administration, H1 2019
  • Number of Products by Stage and Top 10 Routes of Administration, H1 2019
  • Number of Products by Molecule Types, H1 2019
  • Number of Products by Stage and Molecule Types, H1 2019

Keywords
;